Unique ID issued by UMIN | UMIN000043913 |
---|---|
Receipt number | R000050103 |
Scientific Title | Validation research on body-temperature regulation by test-food intakes |
Date of disclosure of the study information | 2022/04/15 |
Last modified on | 2022/04/11 13:14:57 |
Validation research on body-temperature regulation by test-food intakes
Validation research on body-temperature regulation by test-food intakes
Validation research on body-temperature regulation by test-food intakes
Validation research on body-temperature regulation by test-food intakes
Japan |
Healthy male adults
Adult |
Others
NO
To verify some kind of improvement effect in body-temperature regulation by ingesting the test food to the subjects
Safety,Efficacy
Changing rate of core-body temperature (drum temperature)
1. Body weight-changing rate
2. Plasma volume-changing rate
3. Total protein
4. Albumin
5. Serum sodium
6. Serum osmolality
7. Fractional excretion of sodium
8. Creatinine clearance
9. Free water clearance
10. Voided volume
11. Bloodstream (OMEGAZONE)
12. Heartbeat rate (Polar Unite)
13. Subjective symptoms based on a visual analog scale questionnaire (feebleness, thirst, hotness)
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Freely consumption of the test/placebo food (two bottles a day) to the subject for five days at home.
On admission, consumption of the test/placebo food (two bottles a day) to the subject at the appointed time.
20 | years-old | <= |
65 | years-old | > |
Male
(1) Healthy male subjects ranging in age from 20 to 64, at informed consent.
(2) Subjects ranging in BMI from 18.5 to less than 25.0 kg/m2.
(3) Subjects who can give informed consent to participate in this trial, after being provided with an explanation of the protocol detail.
(1) Subjects who have any difficulty in doing exercises with a bicycle ergometer for approximately 30 min.
(2) Subjects falling into the habit of excessive alcohol intake.
(3) Subjects who have the habit of smoking, at the present time and/or within a year before this trial.
(4) Subjects with extremely irregular life rhythm.
(5) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs.
(6) Subjects being under some kind of continuous medical treatment, and/or planning to have it during this trial.
(7) Subjects having drug and/or food allergy.
(8) Subjects who are now under the other clinical tests with some kind of medicine/food, or took part in those within four weeks before this trial, or will join those after giving informed consent to participate in this trial.
(9) Subjects who donated 400 mL of their whole blood within the last three months before this trial.
(10) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.
15
1st name | Kazunori |
Middle name | |
Last name | Kato |
Toyo University
Professor, Director of the center
350-0815
2100 Kujirai, Kawagoe, Saitama 350-0815, Japan
049-239-1397
k-kato@toyo.jp
1st name | Makoto |
Middle name | |
Last name | Ichinohe |
CPCC Company Limited
Clinical Planning Department
101-0047
4F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
EZAKI GLICO CO., LTD.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-5548
IRB@cpcc.co.jp
NO
2022 | Year | 04 | Month | 15 | Day |
Unpublished
Completed
2021 | Year | 03 | Month | 23 | Day |
2021 | Year | 03 | Month | 19 | Day |
2021 | Year | 04 | Month | 15 | Day |
2021 | Year | 06 | Month | 11 | Day |
2021 | Year | 04 | Month | 13 | Day |
2022 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050103